Literature DB >> 19187863

Chronic viral hepatitis as a public health issue in the world.

Daniel Lavanchy1.   

Abstract

This article will focus on the impact caused by chronic viral hepatitis B and C globally and will discuss public health measures that have to be implemented in order to prevent and control these diseases. Chronic viral hepatitis is a major global public health problem, an important cause of morbidity and mortality from sequelae which include chronic hepatitis, cirrhosis and primary liver cancer. Being a 'silent' disease, the contribution of chronic hepatitis to global morbidity and mortality is generally underestimated. Hepatitis B and C prevention and control should seek to reduce both the incidence of new infections and the risk of chronic liver disease. A comprehensive public health prevention programme should include the prevention and detection of HBV and HCV infections, the diagnosis and control of viral hepatitis related chronic liver disease, conducting surveillance and monitoring the effectiveness of prevention activities, and setting up a research agenda.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19187863     DOI: 10.1016/j.bpg.2008.11.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  32 in total

1.  Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.

Authors:  Xiuchan Guo; Yong Zhang; Ji Li; Jingchen Ma; Zuli Wei; Wenjie Tan; Stephen J O'Brien
Journal:  Hepatology       Date:  2011-01-04       Impact factor: 17.425

2.  Hepatitis B prevention and control: Lessons from the East and the West.

Authors:  Monica C Robotin
Journal:  World J Hepatol       Date:  2011-02-27

Review 3.  Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective.

Authors:  Karina Salvatierra; Sabrina Fareleski; Alicia Forcada; F Xavier López-Labrador
Journal:  World J Virol       Date:  2013-02-12

Review 4.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

5.  HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.

Authors:  H N Kim; J Scott; A Cent; L Cook; R A Morrow; B Richardson; K Tapia; K R Jerome; G Lule; G John-Stewart; M H Chung
Journal:  J Viral Hepat       Date:  2011-05-13       Impact factor: 3.728

6.  Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.

Authors:  Lucivalda P M Oliveira; Rosangela P de Jesus; Ramona S S B Boulhosa; Carlos Mauricio C Mendes; Maria Cecilia Gnoatto; Denise C Lemaire; Maria Betania P Toralles; Lourianne N Cavalcante; Andre C Lyra; Luiz G C Lyra
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

7.  Seroepidemiology of hepatitis B virus infection and impact of vaccination.

Authors:  Peng Huang; Li-Guo Zhu; Ye-Fei Zhu; Ming Yue; Jing Su; Feng-Cai Zhu; Hai-Tao Yang; Yun Zhang; Hong-Bing Shen; Rong-Bin Yu; Xiang-Jun Zhai; Zhi-Hang Peng
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 8.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Cost of treating chronic hepatitis B: comparison of current treatment guidelines.

Authors:  Monica Robotin; Yumi Patton; Melanie Kansil; Andrew Penman; Jacob George
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

10.  Knowledge, attitudes and practices among people with chronic hepatitis B attending a hepatology clinic in Malaysia: a cross sectional study.

Authors:  Rosmawati Mohamed; Chirk Jenn Ng; Wen Ting Tong; Suraya Zainol Abidin; Li Ping Wong; Wah Yun Low
Journal:  BMC Public Health       Date:  2012-08-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.